Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression LevelsBiagio Ricciuti, Mark M. Awad, Xinan Wang et al.|JAMA Oncology|2022Cited by 383
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLCJoao V. Alessi, Mark M. Awad, Giuseppe Lamberti et al.|Journal of Thoracic Oncology|2023Cited by 91
Geographic differences in lung cancer: focus on carcinogens, genetic predisposition, and molecular epidemiologyJuan Carlos Laguna, Laura Mezquita, Miguel García-Pardo et al.|Therapeutic Advances in Medical Oncology|2024Cited by 48